[go: up one dir, main page]

TW200716183A - Parakeratosis inhibitor, pore-contracting agent and external composition for skin - Google Patents

Parakeratosis inhibitor, pore-contracting agent and external composition for skin

Info

Publication number
TW200716183A
TW200716183A TW095116238A TW95116238A TW200716183A TW 200716183 A TW200716183 A TW 200716183A TW 095116238 A TW095116238 A TW 095116238A TW 95116238 A TW95116238 A TW 95116238A TW 200716183 A TW200716183 A TW 200716183A
Authority
TW
Taiwan
Prior art keywords
pore
parakeratosis
external composition
skin
skin roughness
Prior art date
Application number
TW095116238A
Other languages
English (en)
Other versions
TWI367762B (zh
Inventor
Mikiko Kaminuma
Masaru Suetsugu
Toshii Iida
Shinji Inomata
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of TW200716183A publication Critical patent/TW200716183A/zh
Application granted granted Critical
Publication of TWI367762B publication Critical patent/TWI367762B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095116238A 2005-05-09 2006-05-08 Parakeratosis inhibitor, pore-contracting agent and external composition for skin TW200716183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005135630A JP4865251B2 (ja) 2005-05-09 2005-05-09 不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物

Publications (2)

Publication Number Publication Date
TW200716183A true TW200716183A (en) 2007-05-01
TWI367762B TWI367762B (zh) 2012-07-11

Family

ID=37396450

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116238A TW200716183A (en) 2005-05-09 2006-05-08 Parakeratosis inhibitor, pore-contracting agent and external composition for skin

Country Status (8)

Country Link
US (1) US8937090B2 (zh)
EP (1) EP1880711B1 (zh)
JP (1) JP4865251B2 (zh)
KR (1) KR101338982B1 (zh)
CN (2) CN101175470B (zh)
ES (1) ES2588930T3 (zh)
TW (1) TW200716183A (zh)
WO (1) WO2006120941A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4971686B2 (ja) * 2006-05-25 2012-07-11 株式会社 資生堂 曳糸性組成物およびそれを用いた睫毛用化粧料、毛髪用化粧料
EP2255780A1 (en) * 2008-03-12 2010-12-01 Shiseido Company, Ltd. Parakeratosis inhibitor, pore shrinking agent or agent for preventing or improving rough skin, and composition for external use on the skin containing the same
JP5558728B2 (ja) * 2008-03-12 2014-07-23 株式会社 資生堂 皮膚外用組成物
JP5300302B2 (ja) * 2008-03-31 2013-09-25 株式会社 資生堂 １−ピペリジンプロピオン酸及び／またはその塩を活性成分とするｓｃｃａ−１産生抑制剤
JP2010090113A (ja) * 2008-09-11 2010-04-22 Shiseido Co Ltd 皮膚化粧料
JP5207901B2 (ja) * 2008-09-26 2013-06-12 株式会社 資生堂 皮膚化粧料
JP2010285411A (ja) * 2009-06-15 2010-12-24 Kawaken Fine Chem Co Ltd 保湿剤、それを含有する毛髪化粧料、皮膚化粧料及び入浴剤
KR101137726B1 (ko) * 2009-09-29 2012-04-24 엔프라니 주식회사 니코티노일 도파민 또는 니코티노일 티라민을 함유하는 화장료 조성물
JP2012051873A (ja) * 2010-08-05 2012-03-15 Shiseido Co Ltd 皮膚化粧料
FR2984121B1 (fr) * 2011-12-16 2014-05-16 Oreal Utilisation de derives acide imido-carboxylique pour diminuer la taille des pores de la peau
FR2984119B1 (fr) * 2011-12-16 2013-12-27 Oreal Composition cosmetique comprenant un acide imido-carboxylique
FR2984120A1 (fr) * 2011-12-16 2013-06-21 Oreal Utilisation de derives acide imido-carboxylique pour matifier la peau grasse
FR2984123B1 (fr) * 2011-12-19 2014-01-10 Oreal Composition cosmetique comprenant un derive d'acide imido-carboxylique sous forme solubilisee
FR2999935A1 (fr) * 2012-12-21 2014-06-27 Oreal Utilisation de derives de l'acide imidocarboxylique pour stimuler l'activite antimicrobienne de la peau
FR2999914B1 (fr) * 2012-12-21 2015-08-07 Oreal Utilisation de derives de l'acide imidocarboxylique pour traiter les alterations de la peau liees a l'age ou au photovieillissement
US20170056352A1 (en) 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
CN106176363B (zh) * 2016-07-26 2019-04-02 西安艾尔菲生物科技有限公司 一种具有细致毛孔功效的化妆品及其制备方法
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
CN112533534B (zh) 2018-08-21 2024-07-16 宝洁公司 用于识别毛孔颜色的方法
IL293721A (en) 2019-12-11 2022-08-01 Inspirna Inc Methods of treating cancer
EP4147199A1 (en) 2020-05-08 2023-03-15 The Procter & Gamble Company Methods for identifying dendritic pores
CN117062594A (zh) 2021-04-21 2023-11-14 株式会社资生堂 化妆品
JPWO2023095685A1 (zh) 2021-11-29 2023-06-01

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234399A1 (de) * 1972-07-17 1974-01-31 Thomae Gmbh Dr K Hautschutzmittel
US4016287A (en) * 1972-07-17 1977-04-05 Boehringer Ingelheim Gmbh Dermatological compositions containing an acylamino-carboxylic acid or an alkyl ester thereof
PH24782A (en) * 1985-10-24 1990-10-30 Sankyo Co Composition containing a penem or carbapenem antibiotic and the use of the same
CA2049151C (en) * 1990-08-16 2001-08-14 Dane Chang Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids
JP3002717B2 (ja) 1991-02-14 2000-01-24 工業技術院長 皮膚化粧料
JP2920443B2 (ja) 1991-05-15 1999-07-19 花王株式会社 角栓除去剤
ATE228834T1 (de) * 1994-09-30 2002-12-15 Oreal Verwendung von einem agonisten eines mit einem chloridkanal assozierten rezeptors zur behandlung von hautfalten
TW508247B (en) * 1997-03-31 2002-11-01 Shiseido Co Ltd Cosmetic or dermatological topical composition
JPH11255632A (ja) * 1998-03-11 1999-09-21 Ajinomoto Co Inc 化粧料組成物
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
CN1093417C (zh) * 1999-11-01 2002-10-30 何国顺 一种毛孔缩小的药物及其制备方法
JP2002153457A (ja) 2000-11-21 2002-05-28 Kyushu Hakusui Corp 医療設備
JP2002241260A (ja) 2001-02-19 2002-08-28 Shiseido Co Ltd 角栓除去用化粧料
DE10133197A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US6919173B2 (en) * 2001-09-10 2005-07-19 Meso Scale Technologies, Llc. Assay buffer, compositions containing the same, and methods of using the same
JP4518367B2 (ja) * 2002-03-25 2010-08-04 株式会社資生堂 毛穴縮小剤
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
US20060116328A1 (en) * 2003-01-20 2006-06-01 Babizhayev Mark A Combined use of carnosinase inhibitor with l-carnosines and composition
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
EP2491980A2 (en) * 2003-11-27 2012-08-29 Shiseido Company Limited Parakeratosis inhibitor and skin preparation for external use
JP4138679B2 (ja) * 2004-02-25 2008-08-27 株式会社資生堂 刺激緩和剤
JP2005281197A (ja) * 2004-03-30 2005-10-13 Shiseido Co Ltd 不全角化抑制剤、毛穴縮小剤及び皮膚外用剤

Also Published As

Publication number Publication date
KR101338982B1 (ko) 2013-12-10
EP1880711A1 (en) 2008-01-23
US8937090B2 (en) 2015-01-20
HK1119060A1 (zh) 2009-02-27
CN102319184B (zh) 2015-03-25
TWI367762B (zh) 2012-07-11
JP4865251B2 (ja) 2012-02-01
JP2006312597A (ja) 2006-11-16
WO2006120941A1 (ja) 2006-11-16
EP1880711A4 (en) 2013-09-04
US20120232111A1 (en) 2012-09-13
EP1880711B1 (en) 2016-07-20
CN102319184A (zh) 2012-01-18
KR20080005219A (ko) 2008-01-10
ES2588930T3 (es) 2016-11-07
CN101175470A (zh) 2008-05-07
CN101175470B (zh) 2011-09-14

Similar Documents

Publication Publication Date Title
TW200716183A (en) Parakeratosis inhibitor, pore-contracting agent and external composition for skin
TW200716184A (en) Inhibitor for parakeratosis, pore reducing agent or skin roughening preventing or ameliorating agent and composition for skin care preparation
ECSP077980A (es) Inhibidores de la actividad akt
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
BR0317183A (pt) Método de usar compostos de aminocianopiridina como inibidores de proteìna quinase-2 ativada por proteìna quinase ativada por mitógeno
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
WO2007011760A3 (en) Inhibitors of mitotic kinesin
MX2009005795A (es) Composiciones, sintesis y metodos para usar inhibidores de colinesterasa basados en indanona.
WO2009126863A3 (en) Pyridyl inhibitors of hedgehog signalling
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
BRPI0413848A (pt) composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
TW200724166A (en) Wrinkle-improving agent
DE60019586D1 (de) Myostatin genpromoter und inhibierung dessen aktivierung
TW200745094A (en) ATM inhibitor
WO2008073332A3 (en) Creatine compositions for skin treatment
IN2015DN03331A (zh)
MX2008016358A (es) Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3.
ATE443044T1 (de) Tace inhibitoren
WO2006014282A3 (en) Prodrugs of hiv protease inhibitors
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
WO2008009860A3 (fr) Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau